Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

To compare the pharmacokinetics of levetiracetam following single and multiple 15-minute intravenous infusions of 1500 mg levetiracetam between Japanese and Caucasian healthy male subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: UCB Japan Co. Ltd.
• Treatments: Etiracetam; Levetiracetam; Piracetam

Criteria

Inclusion Criteria:

• healthy Japanese and Caucasian males with the age between 20 and 40 years old,

• with the body mass index between 20 and 25,

• with the body weight between 60 and 80kg

Exclusion Criteria:

• subjects who have a history or presence of drug addiction or excessive use of alcohol

• current smokers and former smokers who have given up since less than 6 months before the first dose

• heavy caffeine drinker